Reinventing Life Science Startups – Evidence-based Entrepreneurship

Great for Entrepreneurs!

Steve Blank

What if we could increase productivity and stave the capital flight by helping Life Sciences startups build their companies more efficiently?

We’re going to test this hypothesis by teaching a Lean LaunchPad class for Life Sciences and Health Care (therapeutics, diagnostics, devices and digital health) this October at UCSF with a team of veteran venture capitalists.

Part 1 of this post described the issues in the drug discovery. Part 2 covered medical devices and digital health. This post describes what we’re going to do about it.  And why you ought to take this class.


When I wrote Four Steps to the Epiphany and the Startup Owners Manual, I believed that Life Sciences startups didn’t need Customer Discovery. Heck how hard could it be?  You invent a cure for cancer and then figure out where to put the bags of money. (In fact, for oncology, with a successful…

View original post 921 more words

Bad News for Cisco: Orders from the Asian Market Decline


Once again, Cisco started tightening its work force after receiving bad news from its Asian market. Orders from Asia declined 3% and its business in China fell 6%, while orders in the Americas market increased by 5%. The company is just projecting to rise its revenues by 3% to 5% in the current period, compared to 6% in the fourth period. 

The Silicon Valley company is planning to make a huge lay-off in the incoming weeks. They reported to cut about 4,000 jobs, which is about 5% of its entire workforce, despite the jump in profits in the fourth final quarter, which was reported to be 18%. 

Global Recovery Leaded by Developed Economies


During the last years, we have seen an emerging market growing at fast-pace rates every quarter; hence, leading the global economic growth. The main countries experiencing such growth were mainly  the BRIC’s countries, which are Brazil, Russia, India, and China. Nonetheless, this situation has changed this year, for the first time since the start of the financial crisis Japan, The U.S., and Europe together are contributing more to the global growth than the emerging markets according to an estimate by investment firm Bridgewater Associates LP.

Among the factors to this shift: a resurgent Japan, whose economy expanded 2.6% on an annualized basis last quarter reported by the government last Monday. The recovering of the U.S. economy and an expected  slightly EU’s economy expansion that new reports this week are expected to show.

On the other hand, the emerging market countries are experiencing a contraction on their growth. Beijing’s official full-year growth target is 7.5%, making it the year with the slowest growth ever seen since 1990, still surpassing the U.S. pace of 2%, though many analysts comment that China will grow even slower than the government’s target. Brazil, the biggest Latin America’s economy, is also stagnating. Brazil grew just 1% last year after growing at almost 8% in 2010. Global companies investing in the emerging markets are optimistic about these numbers.